More ImpediMed Limited news
ImpediMed LimitedASX: IPD

March 2017 Quarter Results & Investor Conference Call

Apr 25, 2017 at 10:45 PM EDT · Issued by ImpediMed Limited

Filed with ASX · Apr 25, 2017 at 10:45 PM EDT · 2 pages · English

On 6ix: 6ix.com/news/march-2017-quarter-results-and-investor-conference-call

Watch ImpediMed's latest call↗ImpediMed (ASX:IPD) Q1 2027 Earnings Call · Replay · Oct 29Read the transcript of ImpediMed (ASX:IPD) Q1 2027 Earnings Call↗

ImpediMed Limited on 6ix

Earlier from ImpediMed

  • SOZO Shipped to Vanderbilt to Commence At-Home StudyApr 23, 2017
  • Placement of First SOZO Unit at Scripps HealthMar 6, 2017
  • Appendix 4D and Financial Report 31 December 2016Feb 23, 2017
  • Appendix 4C - Quarter Ended 31 December 2016Jan 30, 2017
  • Appendix 4C - Quarter Ended 30 September 2016Oct 25, 2016

Later from ImpediMed

  • L-Dex Study - Significant Reduction in Clinical LymphoedemaMay 17, 2017
  • Macquarie University Commences Lymphoedema Study Using SozoJun 14, 2017
  • SOZO obtains CE Mark for Heart Failure Patient MonitoringJun 20, 2017
  • L-Dex Recommended in Clinical Practice GuidelinesJul 4, 2017
  • IPD Submits FDA 510(k) Application for SOZO for LymphoedemaJul 16, 2017
All ImpediMed news releases↗

Follow ImpediMed into a list and get an email when it puts out news.

Follow ImpediMed
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer